Published date: Dec 31 2024

Journal Title: Sudan Journal of Medical Sciences

Issue title: Sudan JMS: Volume 19 (2024), Issue No. 4

Pages: 509 – 518

DOI: 10.18502/sjms.v19i4.14571

Hagir Abd Rahman Mahmoudhagir3@hotmail.comDepartment of Oral and Maxillofacial Surgery, Faculty of Dental and Oral Medicine, Karary University, Khartoum, Sudan

Ahmed Mohamed Suleimanahmedsvc19@gmail.comDepartment of Oral and Maxillofacial Surgery, Faculty of Dentistry, University of Khartoum, Khartoum, Sudan

Elwaleed Mohamed Elaminwmelamin@aau.edu.sdDepartment of Histopathology and Cytology, Molecular Biology, Faculty of Medical Lab Sciences, Al Zaeim Al Azhari University, Khartoum, Sudan

Sawsan Abdel Rahim Mohammedsawsanaa2003@yahoo.comDepartment of Pathology, Faculty of Medicine, University of Khartoum, Khartoum, Sudan

Background: Human cytomegalovirus (HCMV) is a widespread human pathogen that triggers varying clinical symptoms depending on the host’s age and immune status. It appears that HCMV infection plays a role in the development of numerous types of cancer. This study aimed to identify the presence of HCMV in different kinds of malignant salivary gland tumors in Sudanese patients.
Methods: Eighty-four formalin-fixed paraffin-embedded tissues (FFPE) from Sudanese patients previously diagnosed with salivary gland cancer (SGC) between 2014 and 2022 were selected. All cases include normal salivary gland tissue. Immunohistochemical staining for CMV was performed using monoclonal antibodies to detect the presence of the virus among the studied group.
Results: CMV was detected in only 1 out of 84 SGC cases; an adenoid cystic carcinoma. All adjacent normal salivary gland tissues were negative for the virus.
Conclusion: The absence of CMV in the studied cases suggests that the virus was not involved in developing these malignancies.

[1] Fonseca, F. P., Carvalho, M. V., de Almeida, O. P., Rangel, A. L. C. A., Takizawa, M. C. H., Bueno, A. G., & Vargas, P. A. (2012). Clinicopathologic analysis of 493 cases of salivary gland tumors in a Southern Brazilian population. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 114(2), 230–239. https://doi.org/10.1016/j.oooo.2012.04.008

[2] Wang, X. D., Meng, L. J., Hou, T. T., & Huang, S. H. (2015). Tumours of the salivary glands in northeastern China: A retrospective study of 2508 patients. British Journal of Oral & Maxillofacial Surgery, 53(2), 132–137. https://doi.org/10.1016/j.bjoms.2014.10.008

[3] EI-Naggar, A. K, Chan, J. K. C., Grandis, J. R., Takata, T., & Slootweg, P. J. (Eds.). (2017). WHO classification of head and neck tumours. International Agency.

[4] Jaafari-Ashkavandi, Z., Ashraf, M. J., & Moshaverinia, M. (2013). Salivary gland tumors: A clinicopathologic study of 366 cases in southern Iran. Asian Pacific Journal of Cancer Prevention, 14(1), 27–30. https://doi.org/10.7314/APJCP.2013.14.1.27

[5] Ahmed, S., Yousif, O. Y., & Abuzeid, M. (2018). Tumours of salivary glands in Sudan. International Journal of Otorhinolaryngology, 5(1), 5.

[6] Compton, T. (2004). Receptors and immune sensors: The complex entry path of human cytomegalovirus. Trends in Cell Biology, 14(1), 5–8. https://doi.org/10.1016/j.tcb.2003.10.009

[7] Bate, S. L., Dollard, S. C., & Cannon, M. J. (2010). Cytomegalovirus seroprevalence in the United States: The national health and nutrition examination surveys, 1988–2004. Clinical Infectious Diseases, 50(11), 1439–1447. https://doi.org/10.1086/652438

[8] Malathi, N., Mythili, S., & Vasanthi, H. R. (2014). Salivary diagnostics: A brief review. International Scholarly Research Notices. https: //downloads.hindawi.com/archive/2014/158786.pdf https://doi.org/10.1155/2014/158786

[9] Staras, S. A., Dollard, S. C., Radford, K. W., Flanders, W. D., Pass, R. F., & Cannon, M. J. (2006). Seroprevalence of cytomegalovirus infection in the United States, 1988-1994. Clinical Infectious Diseases, 43(9), 1143–1151. https://doi.org/10.1086/508173

[10] Cannon, M. J., Schmid, D. S., & Hyde, T. B. (2010). Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Reviews in Medical Virology, 20(4), 202– 213. https://doi.org/10.1002/rmv.655

[11] Khairi, S. I., Intisar, K. S., Enan, K. H., Ishag, M. Y., Baraa, A. M., & Ali, Y. H. (2013). Seroprevalence of cytomegalovirus infection among pregnant women at Omdurman Maternity Hospital. Sudan Journal of Medical Laboratory and Diagnosis, 4(4), 45–49. https://doi.org/10.5897/JMLD2013.0075

[12] Ba, H., Siddig, H., Khamis Kafi, S., Al, A., Mohammed, A. N., Fi, Y., Hemmed, A., & Nile, A. (2014). Serodetection of cytomegalovirus antibodies among blood donors in Khartoum state. Multi-disciplinary Journal of Scientific Research & Education, 1.

[13] Hamdan, H. Z., Abdelbagi, I. E., Nasser, N. M., & Adam, I. (2011). Seroprevalence of cytomegalovirus and rubella among pregnant women in western Sudan. Virology Journal, 8(1), 217. https://doi.org/10.1186/1743-422X-8-217

[14] Scheurer, M. E., Bondy, M. L., Aldape, K. D., Albrecht, T., & El-Zein, R. (2008). Detection of human cytomegalovirus in different histological types of gliomas. Acta Neuropathologica, 116, 79– 86. https://doi.org/10.1007/s00401-008-0359-1

[15] Fortunato, E. A., Sanchez, V., Yen, J. Y., & Spector, D. H. (2002). Infection of cells with human cytomegalovirus during S phase results in a blockade to immediate-early gene expression that can be overcome by inhibition of the proteasome. Journal of Virology, 76(11), 5369–5379. https://doi.org/10.1128/JVI.76.11.5369-5379.2002

[16] Harkins, L., Volk, A. L., Samanta, M., Mikolaenko, I., Britt, W. J., Bland, K. I., & Cobbs, C. S. (2002). Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer. Lancet, 360(9345), 1557– 1563. https://doi.org/10.1016/S0140-6736(02)11524-8

[17] Al-Alwany, S., & Ali, S. (2013). Molecular detection of human cytomegalovirus in Iraqi patients with breast cancer. IJABR, 3(3), 454.

[18] Taher, C., de Boniface, J., Mohammad, A. A., Religa, P., Hartman, J., Yaiw, K. C., Frisell, J., Rahbar, A., & Söderberg-Naucler, C. (2013). High prevalence of human cytomegalovirus proteins and nucleic acids in primary breast cancer and metastatic sentinel lymph nodes. PLoS One, 8(2), e56795. https://doi.org/10.1371/journal.pone.0056795

[19] Harkins, L. E., Matlaf, L. A., Soroceanu, L., Klemm, K., Britt, W. J., Wang, W., Bland, K. I., & Cobbs, C. S. (2010). Detection of human cytomegalovirus in normal and neoplastic breast epithelium. Herpesviridae, 1, 8. https://doi.org/10.1186/2042-4280-1-8

[20] Shamran, H. A., Kadhim, H. S., Hussain, A. R., Kareem, A., Taub, D. D., Price, R. L., Nagarkatti, M., Nagarkatti, P. S., & Singh, U. P. (2015). Detection of human cytomegalovirus in different histopathological types of glioma in Iraqi patients. Biomed Research International, 2015. https://doi.org/10.1155/2015/642652

[21] Rahbar, A., Orrego, A., Peredo, I., Dzabic, M., Wolmer- Solberg, N., Strååt, K., Stragliotto, G., & Söderberg- Nauclér, C. (2013). Human cytomegalovirus infection levels in glioblastoma multiforme are of prognostic value for survival. Journal of Clinical Virology, 57(1), 36–42. https://doi.org/10.1016/j.jcv.2012.12.018

[22] Samanta, M., Harkins, L., Klemm, K., Britt, W. J., & Cobbs, C. S. (2003). High prevalence of human cytomegalovirus in prostatic intraepithelial neoplasia and prostatic carcinoma. The Journal of Urology, 170(3), 998–1002. https://doi.org/10.1097/01.ju.0000080263.46164.97

[23] Atula, T., Grénman, R., Klemi, P., & Syrjänen, S. (1998). Human papillomavirus, Epstein-Barr virus, human herpesvirus 8 and human cytomegalovirus involvement in salivary gland tumours. Oral Oncology, 34(5), 391–395. https://doi.org/10.1016/S1368- 8375(98)00023-2

[24] Kärjä, V., Syrjänen, K., & Syrjänen, S. (1997). No Epstein Barr and cytomegalovirus DNA found in salivary gland tumours. ORL; Journal for Oto-Rhino- Laryngology and Its Related Specialties, 59(2), 97– 99. https://doi.org/10.1159/000276917

[25] Jayaraj, G., Sherlin, H. J., Ramani, P., Premkumar, P., & Anuja, N. (2015). Cytomegalovirus and Mucoepidermoid carcinoma: A possible causal relationship? A pilot study. Journal of Oral and Maxillofacial Pathology, 19(3), 319–324. https://doi.org/10.4103/0973-029X.174618

[26] Senft, E., Lemound, J., Stucki-Koch, A., Gellrich, N. C., Kreipe, H., & Hussein, K. (2015). Expression of cyclindependent kinase inhibitor 2A 16, tumour protein 53 and epidermal growth factor receptor in salivary gland carcinomas is not associated with oncogenic virus infection. International Journal of Oral Science, 7(1), 18–22. https://doi.org/10.1038/ijos.2014.28

[27] Radunovic, M., Tomanovic, N., Novakovic, I., Boricic, I., Milenkovic, S., Dimitrijevic, M., Radojevic-Skodric, S., Bogdanovic, L., & Basta-Jovanovic, G. (2016). Cytomegalovirus induces Interleukin-6 mediated inflammatory response in salivary gland cancer. Journal of the Balkan Union of Oncology, 21(6), 1530–1536.

[28] Chen, A. A., Gheit, T., Stellin, M., Lupato, V., Spinato, G., Fuson, R., Menegaldo, A., Mckay- Chopin, S., Dal Cin, E., Tirelli, G., Da Mosto, M. C., Tommasino, M., & Boscolo-Rizzo, P. (2017). Oncogenic DNA viruses found in salivary gland tumors. Oral Oncology, 75, 106–110. https://doi.org/10.1016/j.oraloncology.2017.11.005

[29] Melnick, M., Sedghizadeh, P. P., Allen, C. M., & Jaskoll, T. (2012). Human cytomegalovirus and mucoepidermoid carcinoma of salivary glands: Cell-specific localization of active viral and oncogenic signaling proteins is confirmatory of a causal relationship. Experimental and Molecular Pathology, 92(1), 118–125. https://doi.org/10.1016/j.yexmp.2011.10.011

[30] Rous, P. (1910). A transmissible avian neoplasm (sarcoma of the common fowl). The Journal of Experimental Medicine, 12(5), 696–705. https://doi.org/10.1084/jem.12.5.696

[31] Weiss, R. A. (2012). Oncogenic viruses and cancer transmission. In E. S. Robertson (Ed.), Cancer associated viruses (pp. 101–118). Springer UShttps://doi.org/10.1007/978-1-4614-0016-5_5

[32] Ahmed, H. G., Suliman, R. S. A., Ashankyty, I. M., Albieh, Z. A., & Warille, A. A. (2018). Role of human Cytomegalovirus in the etiology of nasopharyngeal carcinoma. Journal of Cancer Research and Therapeutics, 14(3), 583–586. https://doi.org/10.4103/0973-1482.176175

[33] Kiprian, D., Czarkowska-Paczek, B., Wyczalkowska- Tomasik, A., & Paczek, L. (2018). Human cytomegalovirus and Epstein-Barr virus infections increase the risk of death in patients with head and neck cancers receiving radiotherapy or radiochemotherapy. Medicine, 97(51), e13777. https://doi.org/10.1097/MD.0000000000013777

[34] Nichols, W. G., & Boeckh, M. (2000). Recent advances in the therapy and prevention of CMV infections. Journal of Clinical Virology, 16(1), 25–40. https://doi.org/10.1016/S1386-6532(99)00065-7

[35] Jauhiainen, M. K., Xu, M., Pyöriä, L., Atula, T., Aro, K., Markkanen, A., Haglund, C., Hagström, J., Mäkitie, A. A., Söderlund-Venermo, M., & Sinkkonen, S. T. (2021). The presence of herpesviruses in malignant but not in benign or recurrent pleomorphic adenomas. Tumour Biology, 43(1), 249–259. https://doi.org/10.3233/TUB-211519

[36] Roden, A. C., Vrana, J. A., Koepplin, J. W., Hudson, A. E., Norgan, A. P., Jenkinson, G., Yamaoka, S., Ebihara, H., Monroe, R., Szabolcs, M. J., Majumdar, R., Moyer, A. M., García, J. J., & Kipp, B. R. (2021). Comparison of in situ hybridization, immunohistochemistry, and reverse transcription–droplet digital polymerase chain reaction for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing in tissue. Archives of Pathology & Laboratory Medicine, 145(7), 785–796. https://doi.org/10.5858/arpa.2021-0008-SA

[37] Awan, M. S., Irfan, B., Zahid, I., Mirza, Y., & Ali, S. A. (2017). Comparison of polymerase chain reaction and immunohistochemistry assays for analysing human papillomavirus infection in oral squamous cell carcinoma. Journal of Clinical and Diagnostic Research : JCDR, 11(6), XC10–XC13. https://doi.org/10.7860/JCDR/2017/24742.10119

[38] Duncan, C. G., Leary, R. J., Lin, J. C. H., Cummins, J., Di, C., Schaefer, C. F., Wang, T. L., Riggins, G. J., Edwards, J., Bigner, D., Kopelovich, L., Vogelstein, B., Kinzler, K. W., Velculescu, V. E., & Yan, H. (2009). Identification of microbial DNA in human cancer. BMC Medical Genomics, 2(1), 22. https://doi.org/10.1186/1755-8794-2-22